GeneDx, Prognos Health ENter Strategic Partnership To Help Rare Disease Patients More Rapidly Gain Access To Potential Treatment Options
Portfolio Pulse from Benzinga Newsdesk
GeneDx and Prognos Health have entered into a strategic partnership aimed at helping patients with rare diseases gain quicker access to potential treatment options. The partnership will leverage GeneDx's Whole Genome Sequencing (WGS) capabilities and Prognos Health's predictive analytics to identify patients who may benefit from specific treatments.

July 19, 2023 | 11:17 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
OPKO Health, the parent company of GeneDx, may see a positive impact from this partnership as it could lead to increased usage of GeneDx's WGS capabilities.
The partnership between GeneDx and Prognos Health could lead to increased usage of GeneDx's WGS capabilities, which could potentially increase revenues for OPKO Health.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80